Search

Your search keyword '"Sagae, Satoru"' showing total 44 results

Search Constraints

Start Over You searched for: Author "Sagae, Satoru" Remove constraint Author: "Sagae, Satoru" Database MEDLINE Remove constraint Database: MEDLINE
44 results on '"Sagae, Satoru"'

Search Results

1. Gestational choriocarcinoma.

2. Improvement in radiation techniques for locally advanced cervical cancer during the last two decades.

3. Endometrial carcinosarcoma.

4. Clear cell carcinoma of the endometrium.

5. [A feasibility study on cervical screening in non-attenders invited to undergo HPV self-sampling with cytology triage versus repeat invitation for cytology screening in Hokkaido].

6. Uterine serous carcinoma.

7. Comparison Study of Self-Sampled and Physician-Sampled Specimens for High-Risk Human Papillomavirus Test and Cytology.

8. Contributions of the Japanese Gynecologic Oncology Group (JGOG) in Improving the Quality of Life in Women With Gynecological Malignancies.

9. Advances and Concepts in Cervical Cancer Trials: A Road Map for the Future.

10. Gynecologic Cancer InterGroup (GCIG) consensus review for uterine serous carcinoma.

12. [Clinical stage and therapy].

13. Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the Gynecological Cancer Intergroup (GCIG).

14. Evidence-based guidelines for treatment of uterine body neoplasm in Japan: Japan Society of Gynecologic Oncology (JSGO) 2009 edition.

15. Less impact of adjuvant chemotherapy for stage I clear cell carcinoma of the ovary: a retrospective Japan Clear Cell Carcinoma Study.

16. Cervical Cancer Working Group report.

17. Practice pattern for postoperative management of endometrial cancer in Japan: a survey of the Japanese Gynecologic Oncology Group.

18. The impact of complete surgical staging upon survival in early-stage ovarian clear cell carcinoma: a multi-institutional retrospective study.

19. Favourable prognosis with modified dosing of docetaxel and cisplatin in Japanese patients with ovarian cancer.

20. Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study.

21. Progression-free survival and overall survival of patients with clear cell carcinoma of the ovary treated with paclitaxel-carboplatin or irinotecan-cisplatin: retrospective analysis.

22. Status of surgical treatment procedures for endometrial cancer in Japan: results of a Japanese Gynecologic Oncology Group survey.

23. Adjuvant chemotherapy with irinotecan hydrochloride and cisplatin for clear cell carcinoma of the ovary.

24. Successful delivery after vaginal radical trachelectomy for invasive uterine cervical cancer.

25. [Surgical treatment for ovarian cancer].

26. [Cancer prevention].

27. [Prognostic factors in advanced ovarian cancer patients].

28. [A pilot study of combined chemotherapy with paclitaxel, doxorubicin and cisplatin for endometrial cancer].

30. Epigenetic inactivation of TMS1/ASC in ovarian cancer.

31. Ultrastructural study of benign, low-malignant potential (LMP), and malignant ovarian tumors.

32. Preoperative diagnosis and treatment results in 106 patients with uterine sarcoma in Hokkaido, Japan.

33. The reproducibility of a binary tumor grading system for uterine endometrial endometrioid carcinoma, compared with FIGO system and nuclear grading.

34. Mechanisms of paclitaxel-induced apoptosis in an ovarian cancer cell line and its paclitaxel-resistant clone.

35. A relationship between Matrix metalloproteinase-1 (MMP-1) promoter polymorphism and cervical cancer progression.

36. Comparison of the usefulness between a new universal grading system for epithelial ovarian cancer and the FIGO grading system.

37. Reproductive function after treatment of malignant germ cell ovarian tumors.

38. Proposal of a new scoring scheme for the diagnosis of noninvasive endocervical glandular lesions.

39. Symposium part 3: Should pathologists diagnose endocervical preneoplastic lesions "less than" adenocarcinoma in situ?: Point.

40. Combination therapy with granisetron, methylprednisolone and droperidol as an antiemetic prophylaxis in CDDP-induced delayed emesis for gynecologic cancer.

41. High-dose-rate intracavitary brachytherapy: results of analyses of late rectal complications.

42. Mitotic activity and apoptosis in endocervical glandular lesions.

43. Investigation of the localization of nerves in the uterosacral ligament: determination of the optimal site for uterosacral nerve ablation.

44. Risk Factors for Ovarian Cancers: Do Subtypes Require Separate Treatment in Epidemiological Studies?

Catalog

Books, media, physical & digital resources